Printer Friendly

Retroviruses conference reassuring on new treatments, viral targets, research.

The recent Retroviruses conference in Seattle reported more progress in AIDS research than perhaps any conference in the last few years. But the potential new drugs and research findings are still in early stages, and include some contradictory or confusing results. Experimental treatments may look good in early human tests but may or may not prove safe and effective for long-term use.

Here is an overview on lipoatrophy -- fat wasting -- a problem our readers have asked about. In future issues we expect to cover new drugs, treatment interruption, other lipodystrophy and drug side effects, and many other topics.

Note: the '-M', '-T', or '-W' in the abstract numbers in this conference just means that the presentation was a poster on Monday, Tuesday, or Wednesday. 'LB' in the abstract name means Late Breaker -- new research results that could not be submitted by the regular deadline but were considered important enough to be accepted anyway.

Other Retroviruses Conference Information

A one-hour telephone recording of an expert summary, organized by, is available toll-free at 800-428-6051; when asked for an ID number, enter 227184 for this recording. You will be asked for your name, affiliation, and telephone number. This is a formality; you can say anything, even that you don't want to give the information, and the process will still go forward.

In some cities local AIDS service organizations are presenting programs with expert speakers who review conference highlights. In New York, for example, the National AIDS Treatment Advocacy Project will have a one-day update Saturday April 6, on the Retroviruses conference and on HIV/Hepatitis C co-infection. Advance registration is required due to building security; to register, call NATAP during business hours at either 888-26-NATAP, or 212-219-0106. For other programs, check with service organizations in your area.

For in-depth information, see "Retroviruses Conference Web Coverage" in this issue.
COPYRIGHT 2002 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:AIDS Treatment News
Article Type:Brief Article
Geographic Code:1USA
Date:Mar 8, 2002
Previous Article:AIDS treatment and related conferences, March through December 2002.
Next Article:Retroviruses conference: Some new drugs in the pipeline.

Related Articles
Retroviruses Conference: Live Telephone Report Feb. 7.
Retroviruses conference: Web coverage.
Barcelona conference: new online report.
Retroviruses conference clinical news: interview with Cal Cohen, M.D.
Major HIV treatment conference in Paris--finding reports online.
TMC125: important one-year trial now recruiting in U.S.
HIV "new strain" story: for more information.
Major treatment conference in Rio, July 24-27.
Major study of "discordant" response--viral control but incomplete CD4 response.
The next line of attack: the previous generation of anti-HIV drugs changed AIDS from an untreatable epidemic into a survivable disease. The next crop...

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters